Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib

Although there is no evidence that a brief exposure to imatinib during conception and pregnancy adversely affects the developing fetus, most patients lose their response after treatment interruption. Patients receiving imatinib should be advised to practice adequate contraception.